Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Intact cognitive skills are necessary for independent living, going to work, and managing finances, and any loss of cognitive skills places a burden on society akin to what is seen with Alzheimer's Disease and Related Dementias. The TelePORT Study (Telehealth-Enhanced Patient-Oriented Recovery Trajectories after Intensive Care) is the first post-intensive care syndrome longitudinal long-term cognitive impairment intervention study. The societal effect from long-term cognitive impairment after critical illness is great as many of these patients are employable adults or functional retirees.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Healthy Volunteers: f
View:

• Adults (age ≥45)

• Admitted to a medical or surgical ICU

• Treated for ARF (with mechanical ventilation) and/or septic shock (with vasopressors)

Locations
United States
Ohio
Ohio State University Wexner Medical Center
NOT_YET_RECRUITING
Columbus
Tennessee
Vanderbilt University Medical Center
RECRUITING
Nashville
Contact Information
Primary
Leanne M Boehm, PhD
leanne.boehm@vanderbilt.edu
615-343-1051
Time Frame
Start Date: 2024-03-13
Estimated Completion Date: 2028-05-31
Participants
Target number of participants: 202
Treatments
Experimental: Telemedicine ICU Recovery Clinic
scheduled telemedicine study visits 3 weeks and 3 months after hospital discharge or return-to-home if discharged to another facility
No_intervention: Standard Recovery Conditions (i.e., Control)
Control group participants will proceed with follow-up as determined by the discharging hospital team and directed to use the provided PICS guide to connect with commonly used resources.
Related Therapeutic Areas
Sponsors
Leads: Vanderbilt University
Collaborators: National Institute on Aging (NIA), Ohio State University

This content was sourced from clinicaltrials.gov